tiprankstipranks
Huakang Biomedical Holdings Company Limited (HK:8622)
:8622
Hong Kong Market
8622
Huakang Biomedical Holdings Company Limited
RESEARCH TOOLSreports
Want to see HK:8622 full AI Analyst Report?

Huakang Biomedical Holdings Company Limited (8622) Financial Statements

0 Followers

Huakang Biomedical Holdings Company Limited Financial Overview

Huakang Biomedical Holdings Company Limited's market cap is currently HK$87.63M. The company's EPS TTM is HK$-0.0121; its P/E ratio is -11.85; Huakang Biomedical Holdings Company Limited is scheduled to report earnings on August 28, 2026, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 28.28M¥ 25.36M¥ 24.63M¥ 25.33M¥ 26.13M
Gross Profit¥ 17.77M¥ 17.07M¥ 16.09M¥ 16.91M¥ 16.46M
Operating Income¥ -7.81M¥ -5.01M¥ -7.39M¥ -5.09M¥ -4.58M
EBITDA¥ -6.17M¥ -3.41M¥ -2.55M¥ 188.00K¥ -852.00K
Net Income¥ -5.01M¥ -4.16M¥ -5.78M¥ -3.08M¥ -4.22M
Balance Sheet
Cash & Short-Term Investments¥ 41.96M¥ 36.49M¥ 32.94M¥ 33.30M¥ 36.21M
Total Assets¥ 66.64M¥ 65.22M¥ 65.31M¥ 66.40M¥ 67.06M
Total Debt¥ 4.96M¥ 4.08M¥ 5.14M¥ 1.88M¥ 1.78M
Net Debt¥ -32.00M¥ -27.41M¥ -27.80M¥ -32.83M¥ -34.52M
Total Liabilities¥ 15.46M¥ 11.17M¥ 14.30M¥ 9.88M¥ 9.36M
Stockholders' Equity¥ 51.15M¥ 54.05M¥ 51.02M¥ 56.52M¥ 57.70M
Cash Flow
Free Cash Flow¥ -3.29M¥ -5.05M¥ -1.55M¥ 475.00K¥ -4.71M
Operating Cash Flow¥ -2.21M¥ -3.06M¥ -48.00K¥ 1.29M¥ -2.38M
Investing Cash Flow¥ 2.32M¥ -4.42M¥ -1.15M¥ -6.11M¥ -2.06M
Financing Cash Flow¥ 4.78M¥ 6.30M¥ 1.02M¥ 2.32M¥ -1.37M
Currency in CNY

Huakang Biomedical Holdings Company Limited Earnings and Revenue History

Income Statement >

Huakang Biomedical Holdings Company Limited Debt to Assets

Balance Sheet >

Huakang Biomedical Holdings Company Limited Cash Flow

Cash Flow >

Huakang Biomedical Holdings Company Limited Forecast EPS vs Actual EPS

Earnings >